Trademark Insights

Registry & Judicial Updates: 20 February 2026

Recent examination trends indicate stricter scrutiny of marks derived from INN-based stems and salt-indicative suffixes in pharmaceutical filings. Even partial resemblance to an International Non-Proprietary Name (INN) is increasingly triggering objections under Section 9(1)(b) and relative grounds where structural similarity exists.

Takeaway:
If the proposed mark echoes a drug molecule name (even partially), expect higher examination sensitivity.

Advisory:
Avoid molecule-derived structures and salt abbreviations in brand formation. Ultra-coined, non-INN-rooted marks significantly reduce objection and opposition exposure.

Vishnu
Trademark Advisory
Mobile: +919866512479

Disclaimer: This update is for awareness, and knowledge-sharing for educational purposes only and does not constitute legal opinion.